Stock VEST VESTIAGE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vestiage, Inc.

Equities

VEST

US92548W1053

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 03:58:19 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.021 USD -.--% Intraday chart for Vestiage, Inc. -.--% +4.48%
Apr. 16 Vestiage, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Vestiage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 0.726 1.167
Enterprise Value (EV) 1 0.7347 1.224
P/E ratio 1.25 x -20.1 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -
FCF Yield - -
Price to Book -82.2 x -20.2 x
Nbr of stocks (in thousands) 58,078 58,078
Reference price 2 0.0125 0.0201
Announcement Date 3/21/23 4/16/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - -
EBITDA - -
EBIT 1 -0.0417 -0.0567
Operating Margin - -
Earnings before Tax (EBT) 1 2.123 -0.0489
Net income 1 2.123 -0.0489
Net margin - -
EPS 2 0.009999 -0.000999
Free Cash Flow - -
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 3/21/23 4/16/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 0.01 0.06
Net Cash position 1 - -
Leverage (Debt/EBITDA) - -
Free Cash Flow - -
ROE (net income / shareholders' equity) - 147%
ROA (Net income/ Total Assets) - -
Assets 1 - -
Book Value Per Share 2 -0 -0
Cash Flow per Share 2 0 -
Capex - -
Capex / Sales - -
Announcement Date 3/21/23 4/16/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
VESTIAGE, INC. Stock Vestiage, Inc.
+4.48% 1.22M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VEST Stock
  4. Financials Vestiage, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW